Celltrion launches AVTOZMA IV in the United States following FDA approval
Novartis to launch US direct-to-patient platform for Cosentyx
Vascarta completes VAS-101 osteoarthritis clinical trial
Sen-Jam Pharmaceutical and KVK Tech complete final development deliverables for SJP-002C
OSE Immunotherapeutics forms strategic alliance with Inserm Transfert and Nantes University
ResVita Bio completes face-to-face Pre-IND meeting with FDA for RVB-003
N4 Pharma advances RNA delivery breakthrough with SRI collaboration
EMA recommends marketing approval of Alvotech's Gobivaz biosimilar to Simponi
Evommune reveals further positive data from Phase 2 EVO756 trial
J & D Pharmaceuticals receives Orphan Drug Designation for JD-004
Ascletis presents Phase III results of denifanstat (ASC40) for acne treatment at EADV Congress 2025
Sanofi reports positive phase 2a results for brivekimig in hidradenitis suppurativa